EN | UA
EN | UA

Help Support

Back

Probiotic Bacillus Subtilis emerges as potential solution for functional gastrointestinal disorders

Gastrointestinal disorders and probiotics Gastrointestinal disorders and probiotics
Gastrointestinal disorders and probiotics Gastrointestinal disorders and probiotics

What's new?

In patients with self-reported functional gastrointestinal disorders, Bacillus Subtilis improves particular symptoms associated with constipation and related gastrointestinal dysfunction.

In a phase 1/2A randomized controlled trial, the intake of a proprietary probiotic strain, Bacillus Subtilis [B. Subtilis, BG01-4™], was well-tolerated and effectively alleviated symptoms associated with constipation and related gastrointestinal dysfunction. The researchers aimed to assess the efficacy of BG01-4™ in sachet form in alleviating functional gastrointestinal disorders (FGID) symptoms.

A total of 67 volunteers underwent a 4-week intervention, with 34 receiving BG01-4™ and 33 receiving a placebo. The Gastrointestinal Symptom Rating Scale (GSRS) was used as the assessment tool, with data collected before the intervention, at 2 weeks, and 4 weeks following its completion. Following 4 weeks, the experimental group showed a 33% improvement in one of the three major endpoints—constipation—compared to the placebo group (15%).

Both other major endpoints, diarrhea and total GSRS, exhibited substantial betterment in both the placebo and experimental groups (22%/20% and 26%/32%, respectively). The pre-planned secondary endpoint, indigestion, showed improvement at 4 weeks (32%), but the difference in comparison with the placebo (21%) did not reach significance.

As found, dyspepsia (with a 10% improvement), indigestion (with an 11% improvement), and constipation (with an 18% improvement) clusters showed significant enhancements in the intervention group in comparison with the placebo, as shown in Figure 1:

Hence, BG01-4TM remarkably improves self-reported symptoms of constipation, indigestion, and dyspepsia. Further, more long-term confirmatory studies are needed.

Source:

Nutrients

Article:

Bacillus Subtilis (BG01-4TM) Improves Self-Reported Symptoms for Constipation, Indigestion, and Dyspepsia: A Phase 1/2A Randomized Controlled Trial

Authors:

Craig Patch et al.

Comments (0)

You want to delete this comment? Please mention comment Invalid Text Content Text Content cannot me more than 1000 Something Went Wrong Cancel Confirm Confirm Delete Hide Replies View Replies View Replies ru en ua
Try: